0001209191-18-004591.txt : 20180119 0001209191-18-004591.hdr.sgml : 20180119 20180119170303 ACCESSION NUMBER: 0001209191-18-004591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171227 FILED AS OF DATE: 20180119 DATE AS OF CHANGE: 20180119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pienta Kenneth CENTRAL INDEX KEY: 0001571862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 18538005 MAIL ADDRESS: STREET 1: C/O CURIS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-27 0 0001645460 Cue Biopharma, Inc. CUE 0001571862 Pienta Kenneth 675 W. KENDALL STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer Common Stock 2017-12-27 4 P 0 2000 7.50 A 2000 D Reflects shares of the Issuer's common stock that were purchased in connection with the Issuer's initial public offering. /s/ Kenneth Pienta by Mark Busch, as attorney-in-fact 2018-01-19